NCT06373237

Brief Summary

This is a retrospective review of treatment outcomes from fertility clinics in The Prelude Network who have used Igenomix for PGT-A and have transferred embryos with initial chaotic results, regardless if re-biopsy was performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2024

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 8, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2025

Completed
Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

April 8, 2024

Last Update Submit

July 16, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Embryo re-biopsy rate

    Frequency of re-biopsy post initial chaotic PGT-A result

    2 years

  • Embryo transfer rate

    Frequency of embryo transfer post re-biopsy

    2 years

  • Pregnancy rate

    Frequency of positive serum pregnancy test post embryo transfer of initial chaotic embryo

    2 years

  • Live birth rate

    Frequency of live birth post embryo transfer of initial chaotic embryo

    2 years

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women of any age who have conducted PGT-A via Igenomix who have transferred an embryo with an initial chaotic result.

You may qualify if:

  • Patients that conducted PGT-A via Igenomix who have transferred an embryo with an initial chaotic result.

You may not qualify if:

  • Patients who had multiple embryo transfer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inception Fertility LLC

Houston, Texas, 77081, United States

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2024

First Posted

April 18, 2024

Study Start

March 26, 2024

Primary Completion

April 28, 2025

Study Completion

April 28, 2025

Last Updated

July 20, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations